Fujian Wanchen Biotechnology Group Co., Ltd. (SHE: 300972)
China
· Delayed Price · Currency is CNY 79.39
-1.02 (-1.27%)
Jan 2, 2025, 4:00 PM CST
Fujian Wanchen Biotechnology Group Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 24,946 | 9,234 | 549.11 | 434.7 | 449.89 | 450.87 | Upgrade
|
| Other Revenue | 60.17 | 60.17 | 0.15 | - | 0.1 | 0.04 | Upgrade
|
| Revenue | 25,006 | 9,294 | 549.26 | 434.7 | 449.98 | 450.91 | Upgrade
|
| Revenue Growth (YoY) | 391.22% | 1592.03% | 26.35% | -3.40% | -0.21% | 31.57% | Upgrade
|
| Cost of Revenue | 22,411 | 8,440 | 462.11 | 391.7 | 325.24 | 319.59 | Upgrade
|
| Gross Profit | 2,595 | 854.2 | 87.15 | 43.01 | 124.74 | 131.32 | Upgrade
|
| Selling, General & Admin | 1,889 | 875.54 | 51.39 | 25.21 | 22.04 | 23.49 | Upgrade
|
| Research & Development | 4.22 | 3.31 | 1.95 | 1.99 | 0.43 | 0.17 | Upgrade
|
| Other Operating Expenses | 53.58 | 20.97 | 3.29 | 3.09 | 2.85 | 2.78 | Upgrade
|
| Operating Expenses | 1,947 | 900.52 | 57.41 | 30.32 | 25.33 | 26.73 | Upgrade
|
| Operating Income | 648.15 | -46.32 | 29.74 | 12.68 | 99.41 | 104.59 | Upgrade
|
| Interest Expense | -51.86 | -28.75 | -4.2 | -5.18 | -7.55 | -13.99 | Upgrade
|
| Interest & Investment Income | 10.5 | 1.68 | 3.18 | 3.01 | 0.33 | 0.43 | Upgrade
|
| Currency Exchange Gain (Loss) | -0 | -0 | - | -0 | -0 | - | Upgrade
|
| Other Non Operating Income (Expenses) | -1.95 | -7.22 | -0.2 | -0.07 | 0.03 | -0.22 | Upgrade
|
| EBT Excluding Unusual Items | 604.84 | -80.6 | 28.52 | 10.44 | 92.21 | 90.81 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | 0.2 | 0.03 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -23.18 | -3.26 | -1.66 | -0.49 | -0.1 | -0.15 | Upgrade
|
| Asset Writedown | -4.17 | -4.04 | -0.31 | -0.1 | -0.05 | -0.62 | Upgrade
|
| Other Unusual Items | 43.41 | 3.19 | 14.83 | 19.18 | 4.07 | 2.14 | Upgrade
|
| Pretax Income | 620.9 | -84.72 | 41.58 | 29.06 | 96.13 | 92.19 | Upgrade
|
| Income Tax Expense | 285.52 | 61.3 | 0.04 | 5.61 | - | - | Upgrade
|
| Earnings From Continuing Operations | 335.38 | -146.02 | 41.54 | 23.45 | 96.13 | 92.19 | Upgrade
|
| Minority Interest in Earnings | -277.69 | 63.1 | 6.2 | - | - | - | Upgrade
|
| Net Income | 57.69 | -82.93 | 47.74 | 23.45 | 96.13 | 92.19 | Upgrade
|
| Net Income to Common | 57.69 | -82.93 | 47.74 | 23.45 | 96.13 | 92.19 | Upgrade
|
| Net Income Growth | - | - | 103.57% | -75.61% | 4.28% | 165.38% | Upgrade
|
| Shares Outstanding (Basic) | 165 | 154 | 153 | 141 | 114 | 115 | Upgrade
|
| Shares Outstanding (Diluted) | 174 | 154 | 155 | 141 | 114 | 115 | Upgrade
|
| Shares Change (YoY) | 13.53% | -0.92% | 10.29% | 22.92% | -0.69% | 0.10% | Upgrade
|
| EPS (Basic) | 0.35 | -0.54 | 0.31 | 0.17 | 0.84 | 0.80 | Upgrade
|
| EPS (Diluted) | 0.33 | -0.54 | 0.31 | 0.17 | 0.84 | 0.80 | Upgrade
|
| EPS Growth | - | - | 84.58% | -80.15% | 5.00% | 165.16% | Upgrade
|
| Free Cash Flow | 1,869 | 804.17 | -245.96 | 57.25 | 100.14 | 137.55 | Upgrade
|
| Free Cash Flow Per Share | 10.72 | 5.23 | -1.59 | 0.41 | 0.88 | 1.19 | Upgrade
|
| Dividend Per Share | - | - | - | 0.220 | - | 0.750 | Upgrade
|
| Dividend Growth | - | - | - | - | - | 150.00% | Upgrade
|
| Gross Margin | 10.38% | 9.19% | 15.87% | 9.89% | 27.72% | 29.12% | Upgrade
|
| Operating Margin | 2.59% | -0.50% | 5.42% | 2.92% | 22.09% | 23.20% | Upgrade
|
| Profit Margin | 0.23% | -0.89% | 8.69% | 5.39% | 21.36% | 20.44% | Upgrade
|
| Free Cash Flow Margin | 7.47% | 8.65% | -44.78% | 13.17% | 22.25% | 30.50% | Upgrade
|
| EBITDA | 757.15 | 41.76 | 89.94 | 73.92 | 159.01 | 164.31 | Upgrade
|
| EBITDA Margin | 3.03% | 0.45% | 16.38% | 17.00% | 35.34% | 36.44% | Upgrade
|
| D&A For EBITDA | 108.99 | 88.08 | 60.2 | 61.24 | 59.61 | 59.72 | Upgrade
|
| EBIT | 648.15 | -46.32 | 29.74 | 12.68 | 99.41 | 104.59 | Upgrade
|
| EBIT Margin | 2.59% | -0.50% | 5.42% | 2.92% | 22.09% | 23.20% | Upgrade
|
| Effective Tax Rate | 45.98% | - | 0.10% | 19.31% | - | - | Upgrade
|
| Revenue as Reported | 25,006 | 9,294 | 549.26 | 434.7 | 449.98 | 450.91 | Upgrade
|
| Advertising Expenses | - | 50.2 | 0.42 | 0.07 | 0.34 | 0.3 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.